SCHEMBL1805974

SCHEMBL1805974

COCc1n[nH]c(-c2ncccc2F)c1CO

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 1/20 0.33
GCGR P47871 1/20 0.33
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CBFB Q13951 2/20 0.32
MAPK1 P28482 1/20 0.32
MAP2K4 P45985 1/20 0.32
MAPKAPK2 P49137 1/20 0.32
MAPKAPK3 Q16644 1/20 0.32
MAPK6 Q16659 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
ALOX12 P18054 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806658 0.87 MAPK1 (0.33) PRKCQALDH1A1L3MBTL1MAPK1MAP2K4
SCHEMBL1803609 0.81 PRKCQ (0.32) PRKCQALDH1A1CBFB
SCHEMBL1806119 0.81 ALDH1A1 (0.39) GCGRALDH1A1MAPK1KDM4ENPSR1
SCHEMBL1807759 0.78 TDP2 (0.42) ALDH1A1L3MBTL1KDM4ENPC1HTT
SCHEMBL22912511 0.70 NPC1 (0.40) ALDH1A1L3MBTL1KDM4ENPC1ALOX12
SCHEMBL1807572 0.69 CYP1A2 (0.32)
SCHEMBL1808962 0.68 TTR (0.37) GCGRALDH1A1NPSR1
SCHEMBL1806295 0.68 CA12 (0.35) ALDH1A1L3MBTL1MAPK1KDM4ENPC1
SCHEMBL1806943 0.67 TDP2 (0.43) ALDH1A1L3MBTL1NPC1HTTRAB9A
SCHEMBL1806318 0.64 PDE4D (0.50) ALDH1A1KDM4ENPC1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501703-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060035-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed